Bluestar Genomics’ Pancreatic Cancer Detection Test Achieves High Sensitivity & Specificity
Bluestar Genomics announced the results of a validation study for its early pancreatic cancer detection test.
Read More
Search Results for: diabetes testing
Pancreatic Cancer Could be Diagnosed up to Three Years Earlier
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests.
Read More
Bruker Launches Molecular Phenomics Research Tool for Long COVID Multi-Organ Risk Assessment
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read More
How to Design a Multiple Instruments QC Procedure
Multiple instruments as the core of testing provides a number of advantages and complexities for clinical laboratories.
Read More
COVID Associated with Up to 72% Increase in Type 1 Diabetes Diagnosis for Children
Children who were infected with COVID show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study.
Read More